Survival by time-to-administration of amiodarone, lidocaine, or placebo in shock-refractory out-of-hospital cardiac arrest.
Journal
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
24
02
2023
received:
08
12
2022
accepted:
01
03
2023
medline:
23
8
2023
pubmed:
5
3
2023
entrez:
4
3
2023
Statut:
ppublish
Résumé
Amiodarone and lidocaine have not been shown to have a clear survival benefit compared to placebo for out-of-hospital cardiac arrest (OHCA). However, randomized trials may have been impacted by delayed administration of the study drugs. We sought to evaluate how timing from emergency medical services (EMS) arrival on scene to drug administration affects the efficacy of amiodarone and lidocaine compared to placebo. This is a secondary analysis of the 10-site, 55-EMS-agency double-blind randomized controlled amiodarone, lidocaine, or placebo in OHCA study. We included patients with initial shockable rhythms who received the study drugs of amiodarone, lidocaine, or placebo before achieving return of spontaneous circulation. We performed logistic regression analyses evaluating survival to hospital discharge and secondary outcomes of survival to admission and functional survival (modified Rankin scale score ≤ 3). We evaluated the samples stratified by early (<8 min) and late administration groups (≥8 min). We compared outcomes for amiodarone and lidocaine compared to placebo and adjust for potential confounders. There were 2802 patients meeting inclusion criteria, with 879 (31.4%) in the early (<8 min) and 1923 (68.6%) in the late (≥8 min) groups. In the early group, patients receiving amiodarone, compared to placebo, had significantly higher survival to admission (62.0% vs. 48.5%, p = 0.001; adjusted OR [95% CI] 1.76 [1.24-2.50]), survival to discharge (37.1% vs. 28.0%, p = 0.021; 1.56 [1.07-2.29]), and functional survival (31.6% vs. 23.3%, p = 0.029; 1.55 [1.04-2.32]). There were no significant differences with early lidocaine compared to early placebo (p > 0.05). Patients in the late group who received amiodarone or lidocaine had no significant differences in outcomes at discharge compared to placebo (p > 0.05). The early administration of amiodarone, particularly within 8 min, is associated with greater survival to admission, survival to discharge, and functional survival compared to placebo in patients with an initial shockable rhythm.
Sections du résumé
BACKGROUND
Amiodarone and lidocaine have not been shown to have a clear survival benefit compared to placebo for out-of-hospital cardiac arrest (OHCA). However, randomized trials may have been impacted by delayed administration of the study drugs. We sought to evaluate how timing from emergency medical services (EMS) arrival on scene to drug administration affects the efficacy of amiodarone and lidocaine compared to placebo.
METHOD
This is a secondary analysis of the 10-site, 55-EMS-agency double-blind randomized controlled amiodarone, lidocaine, or placebo in OHCA study. We included patients with initial shockable rhythms who received the study drugs of amiodarone, lidocaine, or placebo before achieving return of spontaneous circulation. We performed logistic regression analyses evaluating survival to hospital discharge and secondary outcomes of survival to admission and functional survival (modified Rankin scale score ≤ 3). We evaluated the samples stratified by early (<8 min) and late administration groups (≥8 min). We compared outcomes for amiodarone and lidocaine compared to placebo and adjust for potential confounders.
RESULTS
There were 2802 patients meeting inclusion criteria, with 879 (31.4%) in the early (<8 min) and 1923 (68.6%) in the late (≥8 min) groups. In the early group, patients receiving amiodarone, compared to placebo, had significantly higher survival to admission (62.0% vs. 48.5%, p = 0.001; adjusted OR [95% CI] 1.76 [1.24-2.50]), survival to discharge (37.1% vs. 28.0%, p = 0.021; 1.56 [1.07-2.29]), and functional survival (31.6% vs. 23.3%, p = 0.029; 1.55 [1.04-2.32]). There were no significant differences with early lidocaine compared to early placebo (p > 0.05). Patients in the late group who received amiodarone or lidocaine had no significant differences in outcomes at discharge compared to placebo (p > 0.05).
CONCLUSIONS
The early administration of amiodarone, particularly within 8 min, is associated with greater survival to admission, survival to discharge, and functional survival compared to placebo in patients with an initial shockable rhythm.
Substances chimiques
Amiodarone
N3RQ532IUT
Lidocaine
98PI200987
Anti-Arrhythmia Agents
0
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
906-917Informations de copyright
© 2023 Society for Academic Emergency Medicine.
Références
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153-e639. doi:10.1161/cir.0000000000001052
Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. 2016;374(18):1711-1722. doi:10.1056/NEJMoa1514204
Kudenchuk PJ, Brown SP, Daya M, et al. Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Am Heart J. 2014;167(5):653-9.e4. doi:10.1016/j.ahj.2014.02.010
Panchal AR, Berg KM, Kudenchuk PJ, et al. 2018 American Heart Association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2018;138(23):e740-e749. doi:10.1161/cir.0000000000000613
Cheskes S, Dorian P, Feldman M, et al. Double sequential external defibrillation for refractory ventricular fibrillation: the DOSE VF pilot randomized controlled trial. Resuscitation. 2020;150:178-184. doi:10.1016/j.resuscitation.2020.02.010
Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single Centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807-1816. doi:10.1016/s0140-6736(20)32338-2
Lupton JR, Jui J, Neth MR, Sahni R, Daya MR, Newgard CD. Development of a clinical decision rule for the early prediction of shock-refractory out-of-hospital cardiac arrest. Resuscitation. 2022;181:60-67. doi:10.1016/j.resuscitation.2022.10.010
Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16_suppl_2):S366-s468. doi:10.1161/cir.0000000000000916
Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115-151. doi:10.1016/j.resuscitation.2021.02.010
Ornato JP, Peberdy MA, Siegel CR, Lindfors R, Ludin T, Garrison D. Delay to initiation of out-of-hospital cardiac arrest EMS treatments. Am J Emerg Med. 2021;41:60-65. doi:10.1016/j.ajem.2020.12.024
Rahimi M, Dorian P, Cheskes S, Lebovic G, Lin S. Effect of time to treatment with antiarrhythmic drugs on return of spontaneous circulation in shock-refractory out-of-hospital cardiac arrest. J Am Heart Assoc. 2022;11(6):e023958. doi:10.1161/jaha.121.023958
Huebinger R, Chan HK, Bobrow B, et al. Time to antiarrhythmic and association with return of spontaneous circulation in the United States. Prehosp Emerg Care. 2022;27:177-183. doi:10.1080/10903127.2022.2044416
Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346(12):884-890. doi:10.1056/NEJMoa013029
Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341(12):871-878. doi:10.1056/nejm199909163411203
Wissa J, Schultz BV, Wilson D, Rashford S, Bosley E, Doan TN. Time to amiodarone administration and survival outcomes in refractory ventricular fibrillation. Emerg Med Australas. 2021;33(6):1088-1094. doi:10.1111/1742-6723.13841
Lee DK, Kim YJ, Kim G, et al. Impact of early intravenous amiodarone administration on neurological outcome in refractory ventricular fibrillation: retrospective analysis of prospectively collected prehospital data. Scand J Trauma Resusc Emerg Med. 2019;27(1):109. doi:10.1186/s13049-019-0688-1
Corazza F, Fiorese E, Arpone M, et al. The impact of cognitive aids on resuscitation performance in in-hospital cardiac arrest scenarios: a systematic review and meta-analysis. Intern Emerg Med. 2022;17:2143-2158. doi:10.1007/s11739-022-03041-6
Lipsky AM, Greenland S. Causal directed acyclic graphs. JAMA. 2022;327(11):1083-1084. doi:10.1001/jama.2022.1816
Adrie C, Cariou A, Mourvillier B, et al. Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J. 2006;27(23):2840-2845. doi:10.1093/eurheartj/ehl335
Maupain C, Bougouin W, Lamhaut L, et al. The CAHP (cardiac arrest hospital prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest. Eur Heart J. 2016;37(42):3222-3228. doi:10.1093/eurheartj/ehv556
Martinell L, Nielsen N, Herlitz J, et al. Early predictors of poor outcome after out-of-hospital cardiac arrest. Crit Care. 2017;21(1):96. doi:10.1186/s13054-017-1677-2
Kiehl EL, Parker AM, Matar RM, et al. C-GRApH: a validated scoring system for early stratification of neurologic outcome after out-of-hospital cardiac arrest treated with targeted temperature management. J Am Heart Assoc. 2017;6(5):e003821. doi:10.1161/jaha.116.003821
Shih HM, Chen YC, Chen CY, et al. Derivation and validation of the SWAP score for very early prediction of neurologic outcome in patients with out-of-hospital cardiac arrest. Ann Emerg Med. 2019;73(6):578-588. doi:10.1016/j.annemergmed.2019.01.017
Daya MR, Leroux BG, Dorian P, et al. Survival after intravenous versus intraosseous amiodarone, lidocaine, or placebo in out-of-hospital shock-refractory cardiac arrest. Circulation. 2020;141(3):188-198. doi:10.1161/circulationaha.119.042240
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149-1160. doi:10.3758/brm.41.4.1149
Haukoos JS, Newgard CD. Advanced statistics: missing data in clinical research--part 1: an introduction and conceptual framework. Acad Emerg Med. 2007;14(7):662-668. doi:10.1111/j.1553-2712.2007.tb01855.x
Newgard CD, Haukoos JS. Advanced statistics: missing data in clinical research-part 2: multiple imputation. Acad Emerg Med. 2007;14(7):669-678. doi:10.1111/j.1553-2712.2007.tb01856.x
Little RJA, Rubin DB. Statistical Analysis with Missing Data. Wiley; 1987.
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377-399. doi:10.1002/sim.4067
van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219-242. doi:10.1177/0962280206074463
Rubin DB. Multiple Imputation for Nonresponse in Surveys. Wiley; 1987.
Binder H, Sauerbrei W, Royston P. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response. Stat Med. 2013;32(13):2262-2277. doi:10.1002/sim.5639
Royston P. Model selection for univariable fractional polynomials. Stata J. 2017;17(3):619-629.
Gold LS, Fahrenbruch CE, Rea TD, Eisenberg MS. The relationship between time to arrival of emergency medical services (EMS) and survival from out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation. 2010;81(5):622-625. doi:10.1016/j.resuscitation.2010.02.004
Coute RA, Nathanson BH, Kurz MC, McNally B, Mader TJ. The association between scene time interval and neurologic outcome following adult bystander witnessed out-of-hospital cardiac arrest. Am J Emerg Med. 2021;46:628-633. doi:10.1016/j.ajem.2020.11.059
Freire-Tellado M, Navarro-Patón R, Mateos-Lorenzo J, Pérez-López G, Pavón-Prieto MP. Prophylactic amiodarone administration on ROSC after a successful first defibrillation. Resuscitation. 2022;173:59-60. doi:10.1016/j.resuscitation.2022.02.010